Published Data Registry

show all
TitleAuthorsJournalPublication year
DOI
PMID
Recessive variants in ZNF142 cause a complex neurodevelopmental disorder with intellectual disability, speech impairment, seizures, and dystonia.(Open Access) Khan K, Zech M, (...), Winkelmann JGenetics in medicine : official journal of the American College of Medical Genetics2019
CSF soluble TREM2 as a measure of immune response along the Alzheimer's disease continuum.(Open Access) Rauchmann BS, Schneider-Axmann T, Alexopoulos P, Perneczky RNeurobiology of aging2019
Myelin in the Central Nervous System: Structure, Function, and Pathology.(Open Access) Stadelmann C, Timmler S, Barrantes-Freer A, Simons MPhysiological reviews2019
A probabilistic atlas of the human inner ear's bony labyrinth enables reliable atlas-based segmentation of the total fluid space.Kirsch V, Nejatbakhshesfahani F, Ahmadi SA, Dieterich M, Ertl-Wagner BJournal of neurology2019
Beyond binary parcellation of the vestibular cortex - A dataset.(Open Access) Kirsch V, Boegle R, (...), Dieterich MData in brief2019
Small vessel disease: mechanisms and clinical implications.(Open Access) Wardlaw JM, Smith C, Dichgans MThe Lancet. Neurology2019
CSF parameters associated with early MRI activity in patients with MS.(Open Access) Klein A, Selter RC, (...), Hemmer BNeurology(R) neuroimmunology & neuroinflammation2019
The Hippo network kinase STK38 contributes to protein homeostasis by inhibiting BAG3-mediated autophagy.(Open Access) Klimek C, Jahnke R, (...), Höhfeld JBiochimica et biophysica acta. Molecular cell research2019
Safety and efficacy of deferiprone for pantothenate kinase-associated neurodegeneration: a randomised, double-blind, controlled trial and an open-label extension study.Klopstock T, Tricta F, (...), Vichinsky EThe Lancet. Neurology2019
The FOsmetpantotenate Replacement Therapy (FORT) randomized, double-blind, Placebo-controlled pivotal trial: Study design and development methodology of a novel primary efficacy outcome in patients with pantothenate kinase-associated neurodegeneration.(Open Access) Klopstock T, Escolar ML, (...), Greblikas FClinical trials (London, England)2019